ImmunityBio Appoints Dr. Jim Yong Kim, Former World Bank President and Global Health Leader, as Vice Chairman
https://www.businesswire.com/news/home/202608...e-Chairman
Dr. Kim will advise on international partnerships and global access initiatives through the newly formed Office of the Executive Chairman
CULVER CITY, Calif.--(BUSINESS WIRE)--ImmunityBio, Inc. (NASDAQ: IBRX), a commercial-stage immunotherapy company, today announced that Dr. Jim Yong Kim has joined the company as Vice Chairman. Dr. Kim will serve in a newly created Office of the Executive Chairman, where he will focus on strengthening the company's international and global relationships. He will report to Executive Chairman and Founder Dr. Patrick Soon-Shiong.
The Office of the Executive Chairman will bring together senior leaders to support Dr. Soon-Shiong on strategy, partnerships, and initiatives intended to advance ImmunityBio’s scientific and clinical programs globally. In his role, Dr. Kim will focus on relationships with governments, health ministries, multilateral institutions, and global health partners, with the goal of supporting access to the company’s immunotherapy platform, clinical programs, and approved therapies where authorized in markets outside the United States.
Dr. Kim brings decades of leadership at the intersection of medicine, public health, development, and global finance. He served as the twelfth president of the World Bank Group from 2012 to 2019, where he set the institution's goals to end extreme poverty by 2030 and to lift up the poorest 40 percent of people in developing countries. During his tenure, the World Bank launched the Pandemic Emergency Financing Facility, one of the first financial instruments built to move money quickly to stop outbreaks before they spread.
In 1987, Dr. Kim co-founded Partners In Health with Dr. Paul Farmer and others, and helped build treatment programs for drug resistant tuberculosis, HIV, and AIDS in some of the poorest communities in Haiti, Peru, and beyond. From 2003 to 2005, he led the World Health Organization's HIV/AIDS department, where he directed the "3 by 5" initiative, the first global target for AIDS treatment, which expanded access to antiretroviral medicines across the developing world. He has also served as president of Dartmouth College and held professorships at Harvard Medical School and the Harvard T.H. Chan School of Public Health. A physician and anthropologist, he is a recipient of a MacArthur Fellowship and was named one of TIME magazine's 100 Most Influential People. He currently serves as Vice Chairman and Senior Advisor at Global Infrastructure Partners, a part of Blackrock, where he supports the work of the emerging markets team. He also serves as the Chancellor of the University of Global Health Equity in Rwanda.
“Dr. Kim has spent his life working to bring care to people and communities that too often face the greatest barriers to access,” said Dr. Patrick Soon-Shiong, Founder, Executive Chairman, and Global Chief Scientific and Medical Officer of ImmunityBio. “Our mission is to harness the power of the immune system to address some of the world’s most challenging diseases. Dr. Kim’s experience across global health, development finance, governments, and multilateral institutions will be invaluable as we work to build the partnerships that can help advance our science, support clinical development, and expand access to our approved therapies around the world.”
“I have spent my career focused on ensuring that scientific and medical advances reach the people who need them most,” said Dr. Jim Yong Kim. “ImmunityBio is pursuing an ambitious vision grounded in immunology, innovation, and global impact that has the potential to improve countless lives. I am excited to work with Dr. Soon-Shiong and the team to build partnerships across governments, health system, and international institutions that can help accelerate research, broaden access and bring the benefits of these advances to patients around the world.”
https://www.businesswire.com/news/home/202608...e-Chairman
Dr. Kim will advise on international partnerships and global access initiatives through the newly formed Office of the Executive Chairman
CULVER CITY, Calif.--(BUSINESS WIRE)--ImmunityBio, Inc. (NASDAQ: IBRX), a commercial-stage immunotherapy company, today announced that Dr. Jim Yong Kim has joined the company as Vice Chairman. Dr. Kim will serve in a newly created Office of the Executive Chairman, where he will focus on strengthening the company's international and global relationships. He will report to Executive Chairman and Founder Dr. Patrick Soon-Shiong.
The Office of the Executive Chairman will bring together senior leaders to support Dr. Soon-Shiong on strategy, partnerships, and initiatives intended to advance ImmunityBio’s scientific and clinical programs globally. In his role, Dr. Kim will focus on relationships with governments, health ministries, multilateral institutions, and global health partners, with the goal of supporting access to the company’s immunotherapy platform, clinical programs, and approved therapies where authorized in markets outside the United States.
Dr. Kim brings decades of leadership at the intersection of medicine, public health, development, and global finance. He served as the twelfth president of the World Bank Group from 2012 to 2019, where he set the institution's goals to end extreme poverty by 2030 and to lift up the poorest 40 percent of people in developing countries. During his tenure, the World Bank launched the Pandemic Emergency Financing Facility, one of the first financial instruments built to move money quickly to stop outbreaks before they spread.
In 1987, Dr. Kim co-founded Partners In Health with Dr. Paul Farmer and others, and helped build treatment programs for drug resistant tuberculosis, HIV, and AIDS in some of the poorest communities in Haiti, Peru, and beyond. From 2003 to 2005, he led the World Health Organization's HIV/AIDS department, where he directed the "3 by 5" initiative, the first global target for AIDS treatment, which expanded access to antiretroviral medicines across the developing world. He has also served as president of Dartmouth College and held professorships at Harvard Medical School and the Harvard T.H. Chan School of Public Health. A physician and anthropologist, he is a recipient of a MacArthur Fellowship and was named one of TIME magazine's 100 Most Influential People. He currently serves as Vice Chairman and Senior Advisor at Global Infrastructure Partners, a part of Blackrock, where he supports the work of the emerging markets team. He also serves as the Chancellor of the University of Global Health Equity in Rwanda.
“Dr. Kim has spent his life working to bring care to people and communities that too often face the greatest barriers to access,” said Dr. Patrick Soon-Shiong, Founder, Executive Chairman, and Global Chief Scientific and Medical Officer of ImmunityBio. “Our mission is to harness the power of the immune system to address some of the world’s most challenging diseases. Dr. Kim’s experience across global health, development finance, governments, and multilateral institutions will be invaluable as we work to build the partnerships that can help advance our science, support clinical development, and expand access to our approved therapies around the world.”
“I have spent my career focused on ensuring that scientific and medical advances reach the people who need them most,” said Dr. Jim Yong Kim. “ImmunityBio is pursuing an ambitious vision grounded in immunology, innovation, and global impact that has the potential to improve countless lives. I am excited to work with Dr. Soon-Shiong and the team to build partnerships across governments, health system, and international institutions that can help accelerate research, broaden access and bring the benefits of these advances to patients around the world.”
